XML 20 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 21.8 $ 49.4
Restricted cash 31.6 62.5
Accounts receivable 536.8 515.8
Prepaid expenses and other current assets 127.0 114.9
Current assets of discontinued operations 0.0 178.8
Total current assets 717.2 921.4
Property and equipment, net 2,939.2 2,581.2
Operating lease right-of-use assets 212.5 193.7
Goodwill 1,263.2 1,237.0
Intangible assets, net 282.3 158.4
Other long-term assets 222.0 230.0
Noncurrent assets of discontinued operations 0.1 1,543.2
Total assets [1] 5,636.5 6,864.9
Current liabilities:    
Current portion of long-term debt 25.2 37.8
Current operating lease liabilities 25.6 23.5
Accounts payable 132.9 134.0
Accrued payroll 168.3 199.4
Accrued interest payable 42.8 44.4
Other current liabilities 181.0 177.3
Current liabilities of discontinued operations 0.1 132.4
Total current liabilities 575.9 748.8
Long-term debt, net of current portion 2,741.8 3,240.5
Long-term operating lease liabilities 199.7 179.6
Self-insured risks 128.5 123.8
Deferred income tax liabilities 83.0 23.3
Other long-term liabilities 45.3 48.9
Noncurrent liabilities of discontinued operations 0.4 100.8
Total liabilities 3,774.6 4,465.7
Commitments and contingencies
Redeemable noncontrolling interests 35.6 42.2
Encompass Health shareholders’ equity:    
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 114,775,056 in 2022; 114,211,057 in 2021 1.1 1.1
Capital in excess of par value 1,730.2 2,289.6
Accumulated income 115.7 141.8
Treasury stock, at cost (14,992,125 shares in 2022 and 14,719,662 shares in 2021) (536.7) (521.2)
Total Encompass Health shareholders’ equity 1,310.3 1,911.3
Noncontrolling interests 516.0 445.7
Total shareholders’ equity 1,826.3 2,357.0
Liabilities and Equity, Total [1] $ 5,636.5 $ 6,864.9
[1] Our consolidated assets as of December 31, 2022 and December 31, 2021 include total assets of variable interest entities of $207.8 million and $226.2 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2022 and December 31, 2021 include total liabilities of the variable interest entities of $47.9 million and $38.2 million, respectively. See Note 4, Variable Interest Entities.